Skip to main content
. 2017 Mar 7;2(1):e5. doi: 10.2196/diabetes.6981

Table 2.

Change in prescription of medication class or dose between baseline and follow-up.

Change in medication prescription or dose between baseline and follow-up n HbA1ca <6.5% at follow-up,
n (%)
Baseline HbA1c (%),
mean (SD)
Follow-up HbA1c (%),
mean (SD)
Increase 13 4 (31) 8.5 (2.0) 7.4 (1.4)
No change 88 57 (65) 7.2 (1.2) 6.5 (1.0)
Decrease 112 47 (42) 8 (1.6) 6.8 (1.1)
Complete elimination of medications 21 17 (81) 6.7 (0.9) 6.1 (0.5)
No medications prescribed 28 22 (79) 7.3 (1.3) 6.3 (1.1)

aHbA1c: hemoglobin A1c.